Blocking the effects of NGF as a route to safe and effective pain relief - Fact or fancy?

Pain

Volumn 152, Issue 10, 2011, Pages 2200-2201

  Hill, Ray ^a  

^a British Pharmacological Society   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NAPROXEN; NERVE GROWTH FACTOR; TANEZUMAB;

ANALGESIA; CHRONIC PAIN; DRUG EFFICACY; DRUG SAFETY; HIP OSTEOARTHRITIS; HUMAN; KNEE OSTEOARTHRITIS; LOW BACK PAIN; NOTE; OSTEOARTHRITIS; PAIN; PRIORITY JOURNAL;

EID: 80053187941     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1016/j.pain.2011.06.015     Document Type: Editorial

References (8)

1. S.D. Brain, and A.D. Grant Vascular actions of calcitonin gene-related peptide and adrenomedullin Physiol Rev 84 2004 903 934 (Pubitemid 38823770)
2. A. Caporale, and C. Emanueli Cardiovascular actions of neurotrophins Physiol Rev 89 2009 279 308
3. F.F. Hefti, A. Rosenthal, P.A. Walicke, S. Wyatt, G. Vergera, D.L. Shelton, and A.M. Davies Novel class of pain drugs based on antagonism of NGF Trends Pharmacol Sci 27 2006 85 91 (Pubitemid 43184029)
4. N. Katz, D.G. Borenstein, C. Birbara, C. Bramson, M.A. Nemeth, M.D. Smith, and M.T. Brown Efficacy and safety of tanezumab in the treatment of chronic low back pain Pain 152 2011 2248 2258
5. N.E. Lane, T.J. Schnitzer, C.A. Birbara, M. Mokhtarani, D.L. Shelton, M.D. Smith, and M.T. Brown Tanezumab for the treatment of pain from osteoarthritis of the knee N Engl J Med 363 2010 1521 1531
6. T. Wang, D. Yu, and M.I. Lamb Trk kinase inhibitors as new treatments for cancer and pain Expert Opin Ther Patents 19 2009 305 319
7. J.N. Wood Nerve growth factor and pain N Engl J Med 363 2010 1572 1573
8. J. Woodcock A difficult balance - pain management, drug safety and the FDA N Engl J Med 361 2009 2105 2107